Serum myeloperoxidase activity and oxidative stress in patients with acute brucellosis

Clinical Biochemistry

Volumn 45, Issue 10-11, 2012, Pages 733-736

  Karahocagil, Mustafa Kasim ^a   Aslan, Mehmet ^a   Ceylan, Mehmet Resat ^a   Cikman, Aytekin ^a   Sunnetcioglu, Mahmut ^a   Kucukoglu, Mehmet Emin ^a   Taskin, Abdullah ^b  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

Acute brucellosis; Atherosclerosis; Catalase activity; Myeloperoxidase activity; Oxidative stress

Indexed keywords

CATALASE; LIPID HYDROPEROXIDE; MYELOPEROXIDASE;

ADULT; ARTICLE; ATHEROGENESIS; BRUCELLOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; ATHEROSCLEROSIS; BRUCELLOSIS; CATALASE; FEMALE; HUMANS; LIPID PEROXIDES; MALE; OXIDATIVE STRESS; PEROXIDASE;

EID: 84862545008     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.03.017     Document Type: Article

References (30)

1. Ertek M., Yazgi{dotless} H., Kadanali{dotless} A., Özden K., Taşyaran M.A. Complications of Brucella Infection among Adults: An 18-Year Retrospective Evaluation. Turk J Med Sci 2006, 36:377-381.
2. Pappas G., Akritidis N., Bosilkovski M., Brucellosis Tsianos E. N Engl J Med 2005, 352:2325-2336.
3. Colmenero J.D., Reguera J.M., Martos F., Sánchez-De-Mora D., Delgado M., Causse M., et al. Complications Associated with Brucella melitensis Infection: A Study of 530 Cases. Medicine (Baltimore) 1996, 75:195-211.
4. Gantt K.R., Goldman T.L., McCormick M.L., Miller M.A., Jeronimo S.M., Nascimento E.T., et al. Oxidative response of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol 2001, 167:893-901.
5. Dieffenbach C.W., Tramont E.C. Innate (general or nonspecific) host defense mechanisms. Principles and Practice of Infectious Diseases 2005, 34-42. Elsevier Churchill Livingstone, Philadelphia. Sixth edition. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
6. Serefhanoglu K., Taskin A., Turan H., Timurkaynak F.E., Arslan H., Erel O. Evaluation of oxidative status in patients with brucellosis. Braz J Infect Dis 2009, 13(4):249-251.
7. Schabath M.B., Spitz M.R., Hong W.K., Delclos G.L., Reynolds W.F., Gunn G.B., et al. A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer 2002, 37(1):35-40.
8. Winterbourn C.C., Vissers M.C., Kettle A.J. Myeloperoxidase. Curr Opin Hematol 2000, 7(1):53-58.
9. Hazell L.J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest Mar 15 1996, 97(6):1535-1544.
10. Malle E., Waeg G., Schreiber R., Gröne E.F., Sattler W., Gröne H.J. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem 2000, 267(14):4495-4503.
11. Kutter D., Devaquet P., Vanderstocken G., Paulus J.M., Marchal V., Gothot A. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit?. Acta Haematol 2000, 104(1):10-15.
12. Daugherty A., Rateri D.L., Dunn J.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994, 94:437-444.
13. Nagra R.M., Becher B., Tourtellotte W.W., Antel J.P., Gold D., Paladino T., et al. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol 1997, 78:97-107.
14. Brennan M.L., Penn M.S., Van Lente F., Nambi V., Shishehbor M.H., Aviles R.J., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003, 349(17):1595-1604.
15. Apostolou F., Gazi I.F., Kostoula A., Tellis C.C., Tselepis A.D., Elisaf M., et al. Persistence of an atherogenic lipid profile after treatment of acute infection with brucella. J Lipid Res 2009, 50:2532-2539.
16. Karaagac L., Koruk S.T., Koruk I., Aksoy N. Decreasing oxidative stress in response to treatment in patients with brucellosis: could it be used to monitor treatment?. Int J Infect Dis 2011, 15(5):346-349.
17. Melek I.M., Erdogan S., Celik S., Aslantas O., Duman T. Evaluation of oxidative stress and inflammation in long term Brucella melitensis infection. Mol Cell Biochem 2006, 293:203-209.
18. Nourooz Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol 1999, 300:58-62.
19. Catalase Aebi H. Methods of Enzymatic Analysis 1974, 673-677. Academic Pres Inc., New York and London. H.U. Bergmeyer (Ed.).
20. Klebanoff S.J., Clark F.A. The neutrophil: function and clinical disorders, 1 1978, 810. Elsevier/North Holland Biomedical Press, Amsterdam, The Netherlands.
21. Young E.J. Brucella species. Principles and Practice of Infectious Diseases 2005, 2669-2674. Elsevier Churchill Livingstone, Philadelphia. Sixth edition. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
22. Tatum F.M., Detilleux P.G., Sacks J.M., Halling S.M. Construction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice. Infect Immun 1992, 60:2663-2669.
23. Ece A., Gurkan F., Kervancyoolu M., Kocamaz H., Güneş A., Atamer Y., et al. Oxidative stress, inflammation and early cardiovascular damage in children with chronic renal failure. Pediatr Nephrol 2006, 21:545-552.
24. Jiang X., Leonard B., Benson R., Baldwin C.L. Macrophage control of Brucella abortus: Role of reactive oxygen intermediates and nitric oxide. Cell Immunol 1993, 151:309-319.
25. Kim J.A., Sha Z., Mayfield J.E. Regulation of Brucella abortus catalase. Infect Immun 2000, 68:3861-3866.
26. Sato K., Watanabe S., Yoshizawa T., Hirose M., Murai T., Sato N. Ammonia, hydrogen peroxide, and monochloramine retard gastric epithelial restoration in rabbit cultured cell model. Dig Dis Sci 1999, 44(12):2429-2434.
27. Klebanoff S.J. Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science 1970, 169(950):1095-1097.
28. Hazell L.J., Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J 1993, 290:165-172.
29. Sugiyama S., Okada Y., Sukhova G.K., Virmani R., Heinecke J.W., Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 2001, 158(3):879-891.
30. Nazligul Y., Aslan M., Horoz M., Celik Y., Dulger A.C., Celik H., et al. The effect on serum myeloperoxidase activity and oxidative status of eradication treatment in patients. Helicobacter pylori infected. Clin Biochem Jun 2011, 44(8-9):647-649.